- Sections
- C - Chimiemétallurgie
- C07D - Composés hétérocycliques
- C07D 243/12 - Benzodiazépines-1, 5Benzodiazépines-1, 5 hydrogénées
Détention brevets de la classe C07D 243/12
Brevets de cette classe: 95
Historique des publications depuis 10 ans
|
6
|
9
|
9
|
10
|
8
|
2
|
6
|
3
|
2
|
0
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Propriétaires principaux
| Proprétaire |
Total
|
Cette classe
|
|---|---|---|
| Nippon Chemiphar Co., Ltd. | 228 |
10 |
| Otsuka Pharmaceutical Co., Ltd. | 1504 |
6 |
| The Johns Hopkins University | 5642 |
5 |
| Purdue Research Foundation | 3571 |
5 |
| The Governors of the University of Alberta | 864 |
4 |
| Zeria Pharmaceutical Co., Ltd. | 97 |
4 |
| Lieber Institute, Inc. | 40 |
4 |
| F. Hoffmann-La Roche AG | 7923 |
3 |
| Constellation Pharmaceuticals, Inc. | 210 |
3 |
| Sanford Burnham Prebys Medical Discovery Institute | 295 |
3 |
| Hoffmann-La Roche Inc. | 3387 |
2 |
| Genentech, Inc. | 3968 |
2 |
| Bayer AG | 3308 |
2 |
| Bayer Pharma AG | 1061 |
2 |
| Commonwealth Scientific and Industrial Research Organisation | 1647 |
2 |
| Sanford-Burnham Medical Research Institute | 126 |
2 |
| Universita' degli Studi di Milano | 232 |
2 |
| University of Pittsburgh - Of the Commonwealth System of Higher Education | 3131 |
2 |
| Fondazione Italiana Sclerosi Multipla—fism Onlus | 3 |
2 |
| Boehringer Ingelheim International GmbH | 4698 |
1 |
| Autres propriétaires | 29 |